Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|April 3, 2019
Selective degradation of CDK6 by a palbociclib based PROTACSandeep Rana, Mourad Bendjennat, Smit Kour, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2022
Dimers of isatin derived α-methylene-γ-butyrolactone as potent anti-cancer agentsSandeep Rana, Smit Kour, Smitha Kizhake, et al.
RSC Chemical Biology|February 7, 2022
Stapling proteins in the RELA complex inhibits TNFα-induced nuclear translocation of RELASmit Kour, Sandeep Rana, Smitha Kizhake, et al.
International Journal of Biological Macromolecules|June 20, 2014
Development and evaluation of paclitaxel loaded PLGA:poloxamer blend nanoparticles for cancer chemotherapyPrem N Gupta, Sharad Jain, Chetan Nehate, et al.
Chemical Biology & Drug Design|April 3, 2020
Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDKSandeep Rana, Smit Kour, Yogesh A Sonawane, et al.
Chemical Communications (Cambridge, England)|June 22, 2017
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)Caroline M Robb, Jacob I Contreras, Smit Kour, et al.
European Journal of Medicinal Chemistry|November 23, 2013
Synthesis, antiproliferative and apoptosis-inducing activity of thiazolo[5,4-d]pyrimidinesBaljinder Singh, Santosh K Guru, Smit Kour, et al.
International Journal of Pharmaceutics|May 10, 2014
Synthesis, characterization and mechanistic-insight into the anti-proliferative potential of PLGA-gemcitabine conjugateVaibhav Khare, Smit Kour, Noor Alam, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 13, 2016
Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacyVaibhav Khare, Amarinder Singh, Girish Mahajan, et al.
ACS Chemical Biology|April 3, 2018
Chemical Genetic Screens Identify Kinase Inhibitor Combinations that Target Anti-Apoptotic Proteins for Cancer TherapyJacob I Contreras, Caroline M Robb, Hannah M King, et al.
Pageof 2